{"id":"W2142506642","doi":"10.1200/jco.2012.44.4489","title":"Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Incyte; American Society of Clinical Oncology; Sanofi","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Placebo; Quality of life (healthcare); Internal medicine; Physical therapy; Clinical trial; Randomized controlled trial; Bone marrow; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006412561,0.0003405589,0.006723811,0.000320505,0.00003429739,0.00001674286,0.00009671381,0.0005650525,0.0004061426],"category_scores_gemma":[0.004371536,0.0001686187,0.001317385,0.0001327861,0.0003368762,0.00009023882,0.00002762538,0.0008000955,0.00001305526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009805093,"about_ca_system_score_gemma":0.0004666614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001183688,"about_ca_topic_score_gemma":0.00001512274,"domain_scores_codex":[0.9909469,0.002475475,0.005475188,0.0002878162,0.0005178312,0.0002967858],"domain_scores_gemma":[0.9727474,0.02243426,0.003934484,0.0002377752,0.000297646,0.0003484217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8145205,0.00457236,0.1479082,0.00001672677,0.003433068,0.0001113458,0.0001755376,0.000009027394,0.00002081727,0.0001577363,0.0001012373,0.02897349],"study_design_scores_gemma":[0.9001879,0.08093502,0.01665851,0.0001885228,0.0008630017,0.0000795253,0.00001977193,0.0000838306,0.0003479164,0.0001475789,0.0003737529,0.000114678],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9855899,0.0003544941,0.00000218858,0.002238324,0.0009103692,0.008481663,0.000002359104,0.00001019423,0.002410493],"genre_scores_gemma":[0.9971766,0.0004527606,0.0001258754,0.001195655,0.0002052004,0.0006605526,0.000002880651,0.0000281595,0.0001522768],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1312497,"threshold_uncertainty_score":0.6876069,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.063216412113048,"score_gpt":0.4266609432678403,"score_spread":0.3634445311547923,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}